Vitamin D supplementation for cystic fibrosis

Cochrane Database of Systematic Reviews

Volumn 2014, Issue 5, 2014, Pages

  Ferguson, Janet H ^a   Chang, Anne B ^b  

^a CHRISTCHURCH HOSPITAL   (New Zealand)

^b MENZIES SCHOOL OF HEALTH RESEARCH   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

1,25 DIHYDROXYERGOCALCIFEROL; 25 HYDROXYVITAMIN D; CALCIUM; PARATHYROID HORMONE; PLACEBO; VITAMIN D; BONE DENSITY CONSERVATION AGENT; CALCIFEDIOL; CALCITRIOL; CALCIUM INTAKE;

BONE DENSITY; BONE MINERAL; BONE MINERALIZATION; CALCIUM BLOOD LEVEL; CLINICAL EFFECTIVENESS; CYSTIC FIBROSIS; DISEASE EXACERBATION; DISEASE SEVERITY; DOSE RESPONSE; DRUG EFFICACY; DRUG MEGADOSE; FOREARM; HIP; HUMAN; LUMBAR SPINE; NUTRITIONAL STATUS; OSTEOPENIC PANCREATIC INSUFFICIENCY; OUTCOME ASSESSMENT; PANCREATIC INSUFFICIENCY; PARATHYROID HORMONE BLOOD LEVEL; POPULATION RESEARCH; PRIORITY JOURNAL; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK ASSESSMENT; SYSTEMATIC REVIEW; TREATMENT DURATION; TREATMENT PLANNING; VITAMIN D DEFICIENCY; ADMINISTRATION AND DOSAGE; ADULT; BLOOD; BONE DISEASES, METABOLIC; CALCIUM INTAKE; CHILD; COMPLICATION; DIET SUPPLEMENTATION; META ANALYSIS; METABOLISM; PANCREAS EXOCRINE INSUFFICIENCY;

ADULT; BONE DENSITY CONSERVATION AGENTS; BONE DISEASES, METABOLIC; CALCIFEDIOL; CALCITRIOL; CALCIUM, DIETARY; CHILD; CYSTIC FIBROSIS; DIETARY SUPPLEMENTS; EXOCRINE PANCREATIC INSUFFICIENCY; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 84942751526     PISSN: 14651858     EISSN: None     Source Type: Journal    
DOI: 10.1002/14651858.CD007298.pub4     Document Type: Review

References (48)

1. Brown SA, Aris RM, Leigh MW, Retsch-Bogart GZ, Caminiti MJ, Jennings-Grant T, et al. Baseline BMD status in children and young adults with CF: calcitriol intervention study [abstract]. Pediatric Pulmonology 2005;40 Suppl 28:354. [CFGD Register: CO20]
2. Deghan Manshadi S, Robert R, Brotherwood M, Tullis E, Stephenson A. A randomized placebo-controlled trial of cholecalciferol for vitamin D deficiency in adults with cystic fibrosis [abstract]. Pediatric Pulmonology 2012;47 Suppl 35:412, Abstract no:515. [CFGD Register: GN228]
3. Grossmann RE, Zughaier S, Kumari M, Seydafkan S, Liu S, Lyles R, et al. Clinical responses to a novel vitamin D supplementation strategy in adult CF patients hospitalized for pulmonary exacerbations [abstract]. Pediatric Pulmonology 2011;46 Suppl 34:404, Abstract 526. [CFGD Register: GN217b]
4. Grossmann RE, Zughaier SM, Kumari M, Seydafkan S, Lyles RH, Liu S, et al. Pilot study of vitamin D supplementation in adults with cystic fibrosis pulmonary exacerbation: A randomized, controlled trial. Dermato-endocrinology 2012;4(2):191-7. [CFGD Register: GN217d; CRS-ID: 5500100000011175]
5. Grossmann RE, Zughaier SM, Liu S, Lyles RH, Tangpricha V. Impact of vitamin D supplementation on markers of inflammation in adults with cystic fibrosis hospitalized for a pulmonary exacerbation. European Journal of Clinical Nutrition 2012;66(9):1072-4. [CFGD Register: GN217c]
6. Kumara M, Colman L, Grossmann R, Wolfenden LL, Tangpricha V. High dose vitamin D supplementation in cystic fibrosis patients hospitalised for respiratory exacerbation [abstract]. Pediatric Pulmonology 2009;44 Suppl 32:Abstract 549. [CFGD Register: GN217a]
7. Haworth CS, Jones A, Selby PL, Adams JE, Mawer EB, Webb AK. Randomised, double blind, placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adults with cystic fibrosis [abstract]. Pediatric Pulmonology 2001;32 Suppl 22:330-1. [CFGD Register: CO18a]
8. Haworth CS, Jones AM, Adams JE, Selby PL, Webb AK. Randomised double blind placebo controlled trial investigating the effect of calcium and vitamin D supplementation on bone mineral density and bone metabolism in adult patients with cystic fibrosis. Journal of Cystic Fibrosis 2004;3(4):233-6. [CFGD Register: CO18b]
9. Hillman LS, Cassidy JT, Popescu MF, Hewett JE, Kyger J, Robertson JD. Percent true calcium absorption, mineral metabolism, and bone mineralization in children with cystic fibrosis: effect of supplementation with vitamin D and calcium. Pediatric Pulmonology 2008;43(8):772-80. [CFGD Register: CO21]
10. Popescu M, Morris J, Hillman L. Calcium and vitamin D supplementation in CF children [abstract]. Pediatric Pulmonology 1998;26 Suppl 17:359, Abstract no: 539.
11. Sciuca S, Turcu O. Correction of low bone mass density in patients with cystic fibrosis [abstract]. Journal of Cystic Fibrosis 2011;10 Suppl 1:S78, Abstract no: 308. [MEDLINE: 97400975;: CO46]
12. Aris RM, Lester GE, Neuringer IP, Winders AW, Gott KK, Rea J, et al. Efficacy of pamidronate for osteoporosis in cystic fibrosis patients following lung transplantation [abstract]. Pediatric Pulmonology 1998;26(Suppl 17):365.
13. Aris RM, Lester GE, Renner JB, Winders A, Denene Blackwood A, Lark RK, et al. Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation. American Journal of Respiratory and Critical Care Medicine 2000;162(3 part 1):941-6.
14. Aris RM, Ontjes DA, Winders AW, Blackwood D, Lester GE. Effect of pamidronate on bone biomarkers in post-transplant osteoporotic cystic fibrosis patients [abstract]. Pediatric Pulmonology 1998;26(Suppl 17):364-5.
15. Gronowitz E, Gilljam M, Hollsing A, Lindblad A, Larko O, Strandvik B. Ultraviolet B radiation improves serum levels of vitamin D in patients with cystic fibrosis (abstract). Pediatric Pulmonology 2003;36(Suppl 25):345.
16. Homola L, Holcikova A, Mikolasek P, Pavelka J. Vitamin D supplementation in children with cystic fibrosis:sunshine, cholecalciferol and ergocalciferol [abstract]. Journal of Cystic Fibrosis 2011;10 Suppl 1:S76, Abstract no: 302. [CFGD Register: GN220; MEDLINE: 97400975]
17. Judd SE, Khazai N, Jeng L, Stecenko A, Wolfenden L, Tangpricha V. Evaluation of ergocalciferol, cholecalciferol or UVB light therapy to improve vitamin D status in cystic fibrosis: a prospective randomized study [abstract]. Pediatric Pulmonology 2008;43(Suppl 31):420.
18. Khazai NB, Judd SE, Jeng L, Wolfenden LL, Stecenko A, Ziegler TR, Tangpricha V. Treatment and prevention of vitamin D insufficiency in cystic fibrosis patients: comparative efficacy of ergocalciferol, cholecalciferol, and UV light. Journal of Clinical Endocrinology and Metabolism 2009;94(6):2037-43. [MEDLINE: 97400975]
19. Aris RM, Merkel PA, Bachrach LK, Borowitz DS, Boyle MP, Elkin SL, et al. Consensus statement: Guide to bone health and disease in cystic fibrosis. Journal of Clinical Endocrinology and Metabolism 2005;90(3):1888-96.
20. Black PN, Scragg R. Relationship between serum 25-hydroxyvitamin d and pulmonary function in the third national health and nutrition examination survey. Chest 2005;128(6):3792-8.
21. Bonifant CM, Shevill E, Chang AB. Vitamin A supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews 2012, Issue 8. [DOI: 10.1002/14651858.CD006751.pub3]
22. Borowitz D, Baker RD, Stallings V. Consensus report on nutrition for pediatric patients with cystic fibrosis. Journal of Pediatric Gastroenterology and Nutrition 2002;35:246-59.
23. Brenckmann C, Papaioannou A. Bisphosphonates for osteoporosis in people with cystic fibrosis. Cochrane Database of Systematic Reviews 2001, Issue 4. [DOI: 10.1002/14651858.CD002010]
24. Cates C. Visual Rx. Online NNT Calculator. http://www.nntonline.net/: Cates C, 2003.
25. Chesney RW. Vitamin D: Can an Upper Limit be Defined?. Journal of Nutrition 1989;119(12 Suppl):1825-8.
26. Deeks J, Higgins J, Altman D. Chapter 9 Analysing data and undertaking meta-analysis. In: Higgins JPT, Green S (editors). Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane-handbook.org.
27. Dimitri P, Bishop N. Rickets. Paediatrics and Child Health 2007;17(7):279-87.
28. Dodge JA, Turck D. Cystic fibrosis: nutritional consequences and management. Best Practice & Research. Clinical Gastroenterology 2006;20(3):531-46.
29. Higgins JPT, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ 2003;327(7414):557-60.
30. Julian PT Higgins, Douglas G Altman and Jonathan AC Sterne on behalf of the Cochrane Statistical Methods Group and the Cochrane Bias Methods Group. Chapter 8: Assessing risk of bias in included studies. In: Higgins JPT, Green S (editors). Cochrane Handbook of Systematic Reviews of Interventions. Version 5.1.0 [updated March 2011]. Available from www.cochrane-handbook.org. The Cochrane Collaboration, 2011.
31. Holick MF. Vitamin D deficiency. New England Journal of Medicine 2007;357(3):266-81.
32. Holick MF, Biancuzzo RM, Chen TC, Klein EK, Young A, Bibuld D, et al. Vitamin D2 is as effective as vitamin D3 in maintaining circulating concentrations of 25-hydroxyvitamin D. Journal of Clinical Endocrinology and Metabolism 2007;Dec 18:[Epub ahead of print]. [DOI: 10.1210/jc.2007-2308]
33. Jagannath VA, Fedorowicz Z, Thaker V, Chang AB. Vitamin K supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews 2013, Issue 4. [DOI: 10.1002/14651858.CD008482.pub3]
34. Joiner TA, Foster C, Shape T. The many faces of vitamin D deficient rickets. Pediatrics in review 2000;21(9):296-302.
35. NIH. Office of Dietary Supplements. Dietary Supplement Fact Sheet: Vitamin D. http://ods.od.nih.gov/factsheets/vitamind.asp (accessed 31st October 2007).
36. Okebukola PO, Kansra S, McCabe H. Vitamin E supplementation in people with cystic fibrosis (Protocol). Cochrane Database of Systematic Reviews 2011, Issue 11. [DOI: 10.1002/14651858.CD009422]
37. Popescu M, Morris J, Hillman L. Calcium and vitamin D supplementation in CF children [abstract]. Pediatric Pulmonology 1998;26 Suppl 17:359.
38. The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). 5.2. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2012.
39. Sethuraman U. Vitamins. Pediatric Review 2006;27(2):44-55.
40. Sinaasappel M, Stern M, Littlewood J, Wolfe S, Steinkamp G, Heijerman HG, et al. Nutrition in patients with cystic fibrosis: a European Consensus. Journal of Cystic Fibrosis 2002;1:51-75.
41. Theodoratou E, Tzoulaki I, Zgaga L, Ioannidis JP. Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials. BMJ 2014;348:g2035.
42. The UK Cystic Fibrosis Trust Bone Mineralisation Working Group. Bone mineralisation in cystic fibrosis. Report of the UK Cystic Fibrosis Trust Bone Mineralisation Working Group. Cystic Fibrosis Trust, February 2007.
43. Wagener JS, Headley AA. Cystic fibrosis: current trends in respiratory care. Respiratory Care 2003;48(3):234-45.
44. Wharton B, Bishop N. Rickets. Lancet 2003;362(9393):1389-400.
45. World Health Organization. Definition of osteoporosis. Assessment of Fracture Risk and Its Application to Screening for Postmenopausal Osteoporosis 1994:1-129.
46. Wright RJ. Make no bones about it: increasing epidemiologic evidence links vitamin D to pulmonary function and COPD. Chest 2005;128(6):3781-3.
47. Ferguson JH, Chang AB. Vitamin D supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews 2010, Issue 6. [DOI: 10.1002/14651858.CD007298.pub2]
48. Ferguson JH, Chang AB. Vitamin D supplementation for cystic fibrosis. Cochrane Database of Systematic Reviews 2012, Issue 4. [DOI: 10.1002/14651858.CD007298.pub3]